| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | +24.9% | +113.2% |
| Cost of Revenue | $848K | +26.8% | +108.9% |
| Gross Profit | $1.7M | +23.9% | +115.4% |
| R&D Expense | $182K | +27.3% | -9.5% |
| SG&A Expense | $3.1M | +10.6% | +80.4% |
| Operating Income | -$1.5M | +0.2% | -38.0% |
| Net Income | -$1.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.5M | -36.4% | +94.1% |
| Accounts Receivable | $85K | -47.5% | -50.3% |
| Inventory | $1.2M | +13.3% | +87.7% |
| Current Assets | $4.2M | -23.8% | +72.4% |
| Total Assets | $5.3M | -19.5% | +56.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.1M | — | — |
| Capital Expenditures | $384K | — | — |
| Investing Cash Flow | -$384K | — | — |
| Financing Cash Flow | -$616K | — | — |
| Free Cash Flow | -$4.5M | — | — |
| -3.9% |
| -49.1% |
| EPS (Basic) | -$0.34 | +0.0% | +53.4% |
| EPS (Diluted) | -$0.34 | +0.0% | +53.4% |
| $2.1M |
| +2.7% |
| +217.1% |
| Total Liabilities | $2.2M | +2.5% | +202.5% |
| Stockholders' Equity | $3.1M | -30.3% | +15.8% |